Drug discontinuation: Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution (DIANEAL PD-2 WITH DEXTROSE, DIANEAL LOW CALCIUM WITH DEXTROSE)
FDA lists 18 presentations as To Be Discontinued. Companies: Vantive US Healthcare LLC.
- Published by source
- 2026-08-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Vantive US Healthcare LLC
- Products
- Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution DIANEAL PD-2 WITH DEXTROSE DIANEAL LOW CALCIUM WITH DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- A business decision was made to discontinue manufacture of the drug.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-08-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #846 | new | 2026-10-22 | 12fb88571d9f…f1c697 | 184af15b62f5…ee0107 |
Chain head: #1094 edf3be25ec2e…478842